Search - tctmd.com

Displaying 41 - 60 of 584

Sort: Relevancy | Date

Podcast TCTMD Talking Points

The TRISCEND II Trial

May 22, 2024

Podcast TCTMD Talking Points

The VIVA Trial

May 15, 2024

Podcast TCTMD Talking Points

The SELECT Trial

May 01, 2024

News Conference News ACC 2024

Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI

Yael L. Maxwell

April 06, 2024

Presentation ACC 2024

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

Presenter: C. Michael Gibson

April 06, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

Shelley Wood

April 03, 2024

Podcast TCTMD Talking Points

The ORBITA-2 Trial

April 03, 2024

Podcast Heart Sounds

March 2024: Art and Arteries

March 27, 2024

Podcast TCTMD Talking Points

The ARIE-HM3 Trial

March 13, 2024

Podcast TCTMD Talking Points

The AZALEA-TIMI Trial

March 06, 2024

Podcast TCTMD Talking Points

The heart-1 Trial of VERVE-101

February 21, 2024

News Daily News

AEGIS-II Misses Primary Endpoint, Dealing New Blow to HDL Hypothesis

Todd Neale

February 14, 2024

Podcast TCTMD Talking Points

Lepodisiran Phase I Trial

February 07, 2024

Podcast TCTMD Talking Points

CLEAR Outcomes Subanalysis

January 24, 2024

Podcast TCTMD Talking Points

The AXIOMATIC-SSP Trial

January 10, 2024

Podcast TCTMD Talking Points

The eBRAVE-AF Trial

January 03, 2024

Podcast TCTMD Talking Points

The INVICTUS Trial

December 07, 2023

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

L.A. McKeown

November 20, 2023

News Conference News AHA 2023

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

L.A. McKeown

November 11, 2023

Podcast TCTMD Talking Points

The FRAME-AMI Trial

October 04, 2023

Advertisement

The TRISCEND II Trial

The VIVA Trial

The SELECT Trial

Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

TCTMD’s Top 10 Most Popular Stories for March 2024

The ORBITA-2 Trial

March 2024: Art and Arteries

The ARIE-HM3 Trial

The AZALEA-TIMI Trial

The heart-1 Trial of VERVE-101

AEGIS-II Misses Primary Endpoint, Dealing New Blow to HDL Hypothesis

Lepodisiran Phase I Trial

CLEAR Outcomes Subanalysis

The AXIOMATIC-SSP Trial

The eBRAVE-AF Trial

The INVICTUS Trial

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

The FRAME-AMI Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content